Next Generation Labs Cancels R-S Synthetic Nicotine Cessation Patent...

Cancellation of the Kaival Patent Contribution Agreement means that all international rights to the R-S synthetic nicotine cessation (NRT) patent portfolio fully reverted to Next Generation Labs in...(PRWeb July 23, 2021)Read the full story at https://www.prweb.com/releases/next_generation_labs_cancels_r_s_synthetic_nicotine_cessation_patent_contribution_agreement_with_kaival_brands_innovation_group_and_kaival_labs_inc/prweb18090990.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news